| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 3.343 | 4.695 | 0 | 0 | 1.011 | - | - | 0 |
| Total Income - EUR | 0 | 7 | 3.343 | 4.695 | 0 | 0 | 1.011 | - | - | 6.923 |
| Total Expenses - EUR | 620 | 9.325 | 1.318 | 1.351 | 701 | 515 | 450 | - | - | 246 |
| Gross Profit/Loss - EUR | -620 | -9.318 | 2.025 | 3.344 | -701 | -515 | 561 | - | - | 6.676 |
| Net Profit/Loss - EUR | -620 | -9.318 | 1.925 | 3.204 | -701 | -515 | 530 | - | - | 5.736 |
| Employees | 0 | 1 | 0 | 0 | 0 | 0 | 0 | - | - | 0 |
Check the financial reports for the company - Bi - Ior Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 |
| Current Assets | 164 | 155 | 1.106 | 644 | 173 | 82 | 1.337 | - | - | 15.168 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 |
| Receivables | 0 | 40 | 39 | 72 | 74 | 73 | 1.276 | - | - | 230 |
| Cash | 164 | 115 | 1.067 | 573 | 99 | 9 | 61 | - | - | 14.938 |
| Shareholders Funds | -575 | -9.887 | -7.795 | -4.448 | -5.063 | -5.482 | -4.830 | - | - | 7.052 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | - | 40 |
| Debts | 739 | 10.042 | 8.901 | 5.093 | 5.236 | 5.564 | 6.167 | - | - | 8.117 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "142 - 142" | |||||||||
| CAEN Financial Year |
142
|
|||||||||
Comments - Bi - Ior Bio Srl